Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05715164Phase 1Unknown
Phase 1, randomised, open-label trial (3 arms), sponsored by Alternative Research Initiative. Primary endpoints: Number of participants reported adverse events of e-cigarettes or nicotine pouches at 60 Weeks, Change in the number of combustible cigarettes per day at 60 Weeks and 1 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05715164.